Wolf Amparo, Goncalves Sandy, Salehi Fateme, Bird Jeff, Cooper Paul, Van Uum Stan, Lee Donald H, Rotenberg Brian W, Duggal Neil
Division of Neurosurgery.
Department of Medical Imaging, and.
J Neurosurg. 2016 Jun;124(6):1627-33. doi: 10.3171/2015.5.JNS1576. Epub 2015 Oct 23.
OBJECT The relationship between headaches, pituitary adenomas, and surgical treatment of pituitary adenomas remains unclear. The authors assessed the severity and predictors of self-reported headaches in patients referred for surgery of pituitary adenomas and evaluated the impact of endoscopic transsphenoidal surgery on headache severity and quality of life (QOL). METHODS In this prospective study, 79 patients with pituitary adenomas underwent endoscopic transsphenoidal resection and completed the Headache Impact Test (HIT-6) and the 36-Item Short Form Health Survey (SF-36) QOL questionnaire preoperatively and at 6 weeks and 6 months postoperatively. RESULTS Preoperatively, 49.4% of patients had mild headache severity, 13.9% had moderate severity, 13.9% had substantial severity, and 22.8% had intense severity. Younger age and hormone-producing tumors predisposed greater headache severity, while tumor volume, suprasellar extension, chiasmal compression, and cavernous sinus invasion of the pituitary tumors did not. Preoperative headache severity was found to be significantly associated with reduced scores across all SF-36 QOL dimensions and most significantly associated with mental health. By 6 months postoperatively, headache severity was reduced in a significant proportion of patients. Of the 40 patients with headaches causing an impact on daily living (moderate, substantial, or intense headache), 70% had improvement of at least 1 category on HIT-6 by 6 months postoperatively, while headache worsened in 7.6% of patients. The best predictors of headache response to surgery included younger age, poor preoperative SF-36 mental health score, and hormone-producing microadenoma. CONCLUSIONS The results of this study confirm that surgery can significantly improve headaches in patients with pituitary adenomas by 6 months postoperatively, particularly in younger patients whose preoperative QOL is impacted. A larger multicenter study is underway to evaluate the long-term effect of surgery on headaches in this patient group.
目的 头痛、垂体腺瘤与垂体腺瘤手术治疗之间的关系仍不明确。作者评估了因垂体腺瘤手术而就诊患者自我报告的头痛严重程度及预测因素,并评估了内镜经蝶窦手术对头痛严重程度和生活质量(QOL)的影响。方法 在这项前瞻性研究中,79例垂体腺瘤患者接受了内镜经蝶窦切除术,并在术前、术后6周和6个月完成了头痛影响测试(HIT-6)和36项简短健康调查(SF-36)生活质量问卷。结果 术前,49.4%的患者头痛严重程度为轻度,13.9%为中度,13.9%为重度,22.8%为剧烈程度。年龄较小和分泌激素的肿瘤易导致更严重的头痛,而垂体肿瘤的体积、鞍上扩展、视交叉受压和海绵窦侵犯则不然。术前头痛严重程度与所有SF-36生活质量维度的得分降低显著相关,与心理健康的相关性最为显著。术后6个月时,相当一部分患者的头痛严重程度有所降低。在40例头痛对日常生活造成影响(中度、重度或剧烈头痛)的患者中,70%在术后6个月时HIT-6至少改善了1个等级,而7.